Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Opinions of real-world clinicians on endocrine resistance in HR+/HER2-mBC: Results from the RETRACT survey of US oncologists
    Meeting Abstract

    Gradishar, W. J.; Hamilton, E. P.; Mahtani, R. L.; Hurvitz, S. A.; Jhaveri, K. L.; Tolaney, S. M.; Rugo, H. S.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Opinions of real-world clinicians regarding visceral crisis in HR+/HER2-mBC: Results from the RETRACT survey of US oncologists
    Meeting Abstract

    Jhaveri, K. L.; Gradishar, W. J.; Hamilton, E. P.; Hurvitz, S. A.; Mahtani, R. L.; Tolaney, S. M.; Rugo, H. S.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Prediction of real-world progression free survival (rwPFS) using a multimodal machine learning (ML) model for patients with HR+HER2-metastatic breast cancer (mBC) undergoing first line (1L) treatment with cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) and endocrine therapy (ET)
    Meeting Abstract

    Razavi, P.; An, J. A. R.; Erazo, T.; Schwartz, P.; Ferrer, L.; Gallinato, O.; Papillon, L.; Colin, T.; Bossy, M.; Andre, R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Tumor-wide RNA splicing aberrations and their potential as therapeutic neoantigen targets
    Meeting Abstract

    Kwok, D.; Stevers, N.; Etxeberria, I.; Nejo, T.; Cove, M. C.; Chen, L.; Jung, J.; Okada, K.; Lakshmanachetty, S.; Gallus, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Genomic predictors of brain metastases in breast cancer
    Meeting Abstract

    Safonov, A.; Smith, D. R.; Nandakumar, S.; Ferraro, E.; Shen, J.; Khatri, I. S.; Kumar, R.; An, J. A. R.; Jee, J.; Robson, M. E.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Treatment patterns, genomic characteristics, and outcomes among patients with metastatic lobular breast cancer
    Meeting Abstract

    Shen, S.; Pareja, F.; White, C.; Chen, Y.; Safonov, A.; Razavi, P.; Dang, C. T.; Jhaveri, K. L.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Effect of post-discharge symptom monitoring on hospital readmissions: A randomized trial
    Meeting Abstract

    Daly, R. M.; Mao, J. J.; Cracchiolo, J. R.; Holland, J. C.; Huang, J.; Ebstein, A. M.; Walters, C.; Ackerman, J.; Raj, N. P.; Sanford, R. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Phase 1 trial of exercise as first-line therapy for hormone receptor (HR)–positive advanced breast cancer (TBCRC 054)
    Meeting Abstract

    Iyengar, N. M.; Lavery, J. A.; Carlson, A.; Castillo, V.; Lehman, S.; Michalski, M. G.; Harrison, J.; Braun, A.; Flores, J.; Chun, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Effect of ERBB2 activating mutations on enhanced internalization and activity of trastuzumab deruxtecan in HER2-non-amplified metastatic breast cancer
    Meeting Abstract

    Mai, N.; Liu, B.; Safonov, A.; Shen, S.; Zelizer, S.; White, C.; Chen, Y.; Razavi, P.; Jhaveri, K. L.; Modi, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Treatment patterns in HR+/HER2-metastatic breast cancer (MBC) with co-occurring PIK3CA and ESR1 mutations
    Meeting Abstract

    Teysir, J.; Shen, S.; White, C.; Chen, Y.; Razavi, P.; Jhaveri, K. L.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save